GCG and osteoporosis: Osteoporosis and loss of bone mass is frequently observed in patients receiving long-term parenteral nutrition [824,825], and bone remodeling is greater upon oral relative to intravenous glucose administration [826], indicating that bone remodeling is potentially under control of gastrointestinal hormones, including the incretins and the related peptide GLP-2 [822,827,828].